Holen Sie sich die Stockscreener-App
405.05
0.77%
3.09
Handel nachbörslich:
405.05
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HCA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$401.96
Offen:
$401.77
24-Stunden-Volumen:
702.00K
Relative Volume:
0.51
Marktkapitalisierung:
$94.78B
Einnahmen:
$72.70B
Nettoeinkommen (Verlust:
$6.88B
KGV:
17.03
EPS:
23.79
Netto-Cashflow:
$7.29B
1W Leistung:
-1.25%
1M Leistung:
+21.16%
6M Leistung:
+26.21%
1J Leistung:
+3.81%
1-Tages-Spanne:
$398.82
$406.87
1-Wochen-Bereich:
$398.82
$412.00
52-Wochen-Spanne:
$289.98
$417.14
Hca Healthcare Inc Stock (HCA) Company Profile
Firmenname
Hca Healthcare Inc
Sektor
Branche
Telefon
(615) 344-9551
Adresse
ONE PARK PLZ, NASHVILLE, TN
Vergleichen Sie HCA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
405.05 | 94.06B | 72.70B | 6.88B | 7.29B | 23.79 |
|
THC
Tenet Healthcare Corp
|
181.95 | 15.91B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
25.15 | 14.95B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
EHC
Encompass Health Corp
|
123.58 | 12.28B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
182.41 | 11.55B | 16.08B | 1.20B | 1.06B | 17.82 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-07-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-29 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Fortgesetzt | JP Morgan | Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Eingeleitet | UBS | Buy |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-13 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Hochstufung | Goldman | Neutral → Buy |
| 2019-04-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-11-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Bestätigt | Citigroup | Neutral |
| 2017-11-01 | Bestätigt | Mizuho | Buy |
| 2017-07-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Eingeleitet | Argus | Buy |
Alle ansehen
Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten
Trend analysis for HCA Healthcare Inc. this weekMarket Performance Summary & Community Consensus Picks - Newser
What the charts say about HCA Healthcare Inc. todayJuly 2025 Summary & Real-Time Market Sentiment Reports - Newser
HCA Healthcare Inc. stock trend outlook and recovery path2025 Volume Leaders & Weekly Momentum Picks - Newser
HCA Healthcare Rises 0.77% on Low Volume Trailing 349th in Market Activity - AInvest
HCA Healthcare Outperforms Market Over Past 10 Years with 16.97% Annual Return - AInvest
Cantor Fitzgerald Maintains Buy Rating on HCA Healthcare with $444 Price Target - AInvest
HCA Healthcare, Inc. to Present at September Healthcare Conference | HCA Stock News - GuruFocus
HCA Healthcare, Inc. To Present At September Healthcare Conference - Barchart.com
Will HCA Healthcare Inc. rebound enough to break even2025 Technical Overview & Stock Timing and Entry Methods - Newser
Applying chart zones and confluence areas to HCA Healthcare Inc.Trade Performance Summary & High Win Rate Trade Alerts - Newser
Applying Elliott Wave Theory to HCA Healthcare Inc.Share Buyback & Growth Focused Stock Reports - Newser
Short interest data insights for HCA Healthcare Inc.2025 Short Interest & Accurate Technical Buy Alerts - Newser
What technical models suggest about HCA Healthcare Inc.’s comebackJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - Newser
Stock Analysis | HCA Healthcare OutlookMixed Signals Amid Volatility and Analyst Neutrality - AInvest
Is HCA Healthcare Inc. meeting your algorithmic filter criteria2025 Market Overview & Verified Swing Trading Watchlists - Newser
Applying big data sentiment scoring on HCA Healthcare Inc.July 2025 Retail & Smart Allocation Stock Tips - Newser
HCA Healthcare Foundation present’s a $25,000 Check to the United Way of Marion County - 352today
Evaluating HCA Healthcare Inc. with trendline analysisJuly 2025 Weekly Recap & Accurate Buy Signal Notifications - Newser
Analyzing net buyer seller activity in HCA Healthcare Inc.Weekly Gains Summary & Consistent Profit Focused Trading Strategies - Newser
Published on: 2025-08-26 09:08:52 - Newser
Cantor Fitzgerald Reiterates Overweight on HCA Healthcare, Raises PT to $444 - AInvest
Tools to assess HCA Healthcare Inc.’s risk profile2025 Analyst Calls & Real-Time Buy Zone Alerts - Newser
Can technical indicators confirm HCA Healthcare Inc.’s reversalMarket Risk Summary & Free Low Drawdown Momentum Trade Ideas - Newser
Custom watchlist performance reports with HCA Healthcare Inc.Weekly Profit Summary & Risk Managed Investment Strategies - Newser
Will HCA Healthcare Inc. see short term momentum2025 Volatility Report & Growth-Oriented Investment Plans - Newser
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term - sharewise.com
HCA Healthcare’s 0.54% Decline and 274th Volume Rank Reflect Legal Scrutiny and Investor Caution - AInvest
Centerpoint Medical Center names new CEO - The Business Journals
HCA Healthcare Inc. stock daily chart insightsEarnings Growth Summary & Safe Entry Trade Signal Reports - Newser
What makes HCA Healthcare Inc. stock price move sharplyJuly 2025 Movers & Daily Stock Trend Reports - Newser
What’s next for HCA Healthcare Inc. stock priceJuly 2025 Gainers & Weekly Breakout Opportunity Watchlist - Newser
Building trade automation scripts for HCA Healthcare Inc.July 2025 Fed Impact & High Accuracy Investment Signals - Newser
How to track smart money flows in HCA Healthcare Inc.IPO Watch & Long-Term Investment Growth Plans - Newser
Should you wait for a breakout in HCA Healthcare Inc.Market Growth Report & Community Consensus Picks - Newser
Can trapped investors hope for a rebound in HCA Healthcare Inc.Trade Ideas & Daily Oversold Bounce Ideas - Newser
Insider Selling at HCA Healthcare: A Warning Signal Amid Evolving Healthcare and AI-Driven Infrastructure Trends? - AInvest
Insiders At HCA Healthcare Sold US$9.4m In Stock, Alluding To Potential Weakness - Yahoo Finance
Are Wall Street Analysts Bullish on HCA Healthcare Stock? - MSN
Are Wall Street Analysts Bullish On HCA Healthcare Stock? - Barchart.com
Agree To Buy HCA Healthcare At $350, Earn 5.6% Using Options - Nasdaq
HCA Healthcare Stock Rises on Antitrust Settlement as 140th-Most-Traded Shares Reflect Healthcare Sector Scrutiny - AInvest
HCA Healthcare Inc. stock outperforms competitors on strong trading day - MarketWatch
HCA's TriStar Centennial plans $25M rehab unit expansion in Nashville - The Business Journals
American Healthcare's Golden Cross and Rising Sales Signal Strong Buy Opportunity - AInvest
HCA Healthcare stock price target raised to $417 from $404 at Bernstein - Investing.com
HCA Healthcare Reaches Analyst Target Price - Nasdaq
Bernstein Adjusts Price Target on HCA Healthcare to $417 From $404, Maintains Market Perform Rating - MarketScreener
Understanding the Impact of HCA Healthcare’s Settlement - regulatoryoversight.com
Finanzdaten der Hca Healthcare Inc-Aktie (HCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.06%
1.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):